XML 14 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

During the quarter ended March 31, 2026, the following officers adopted a "Rule 10b5-1 trading arrangement" (as such terms are defined in Item 408(a) of Regulation S-K) as noted in the table below.

 

 

 

 

 

 

 

Trading Arrangement

 

 

 

 

 

Name and Title

 

Action

 

Date

 

Rule 10b5-1

 

Non-Rule 10b5-1

 

Total Shares to be Sold

 

 

Expiration Date

Paul Hastings
Chief Executive Officer

 

Adoption

 

1/22/2026

 

X

 

 

 

 

300,000

 

 

3/19/2027

Nadir Mahmood
President

 

Adoption

 

2/18/2026

 

X

 

 

 

 

205,416

 

 

5/28/2027

Shawn Rose
Chief Medical Officer and Head of Research & Development

 

Adoption

 

2/12/2026

 

X

 

 

 

 

177,250

 

 

5/28/2027
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Paul Hastings  
Trading Arrangements, by Individual  
Name Paul Hastings
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 1/22/2026
Expiration Date 3/19/2027
Arrangement Duration 421 days
Aggregate Available 300,000
Nadir Mahmood  
Trading Arrangements, by Individual  
Name Nadir Mahmood
Title President
Rule 10b5-1 Arrangement Adopted true
Adoption Date 2/18/2026
Expiration Date 5/28/2027
Arrangement Duration 464 days
Aggregate Available 205,416
Shawn Rose  
Trading Arrangements, by Individual  
Name Shawn Rose
Title Chief Medical Officer and Head of Research & Development
Rule 10b5-1 Arrangement Adopted true
Adoption Date 2/12/2026
Expiration Date 5/28/2027
Arrangement Duration 470 days
Aggregate Available 177,250